Publications by authors named "Joseph Alderman"

Objectives: To review the information provided for self-test devices sold in high street shops in the UK and to assess their suitability for informed decision making based on use, interpretation, and post-test actions.

Design: Cross sectional review of information on self-test boxes and instructions for use leaflets.

Setting: Supermarkets, pharmacies, and health and wellbeing shops within a 10 mile radius of the University of Birmingham's campus at Edgbaston in 2023.

View Article and Find Full Text PDF

Objectives: To review the evidence base, clinical performance claims, and usability and safety of self-tests available for sale on the UK high street.

Design: Cross sectional review of self-tests-regulation, evidence of performance, usability, and safety.

Setting: Tests were identified from supermarkets, pharmacies, and health and wellbeing shops within a 10 mile radius of the University of Birmingham Edgbaston Campus in 2023.

View Article and Find Full Text PDF

When evaluating the performance of a model for individualised risk prediction, the sample size needs to be large enough to precisely estimate the performance measures of interest. Current sample size guidance is based on precisely estimating calibration, discrimination, and net benefit, which should be the first stage of calculating the minimum required sample size. However, when a clinically important threshold is used for classification, other performance measures are also often reported.

View Article and Find Full Text PDF

Procurement carries legal requirements across public services in the UK but, for stakeholders in clinical Artificial Intelligence (AI) innovation, it is often poorly understood. This perspective piece summarises insights from a cross-sector workshop exploring the role of procurement frameworks in supporting AI innovation in the National Health Service (NHS). The significant characteristics of AI from a procurement perspective are identified and their consequences are explored.

View Article and Find Full Text PDF

Rigorous study design and analytical standards are required to generate reliable findings in healthcare from artificial intelligence (AI) research. One crucial but often overlooked aspect is the determination of appropriate sample sizes for studies developing AI-based prediction models for individual diagnosis or prognosis. Specifically, the number of participants and outcome events required in datasets for model training and evaluation remains inadequately addressed.

View Article and Find Full Text PDF

Background: Heart failure (HF) is a life-threatening disease affecting 64 million people worldwide. Artificial intelligence (AI) technologies are being developed for use in HF to support early diagnosis and stratification of treatment. The performance characteristics of AI technologies are influenced by whether the data used during the AI lifecycle reflects the populations for which the AI is used.

View Article and Find Full Text PDF

Clinical prediction models estimate an individual’s risk (probability) of a health related outcome to help guide patient counselling and clinical decision making. Most models provide a single point estimate of risk but without the associated uncertainty. Riley and colleagues argue that this needs to change, as understanding uncertainty of risk estimates helps to inform critical evaluation of a model and may impact shared decision making.

View Article and Find Full Text PDF
Article Synopsis
  • There is a significant risk of reinforcing existing health inequalities in AI health technologies due to biases, primarily stemming from the datasets used.
  • The STANDING Together recommendations focus on transparency in health datasets and proactive evaluation of their impacts on different population groups, informed by a comprehensive research process with over 350 global contributors.
  • The 29 recommendations are divided into guidance for documenting health datasets and strategies for using them, aiming to identify and reduce algorithmic biases while promoting awareness of the inherent limitations in all datasets.
View Article and Find Full Text PDF
Article Synopsis
  • This review analyzes various mammography datasets used for AI development in breast cancer screening, focusing on their transparency, content, and accessibility.
  • A search identified 254 datasets, with only 28 being accessible; most datasets came from Europe, East Asia, and North America, raising concerns over poor demographic representation.
  • The findings highlight significant gaps in diversity within these datasets, underscoring the need for better documentation and inclusivity to enhance the effectiveness of AI technologies in breast cancer research.
View Article and Find Full Text PDF
Article Synopsis
  • During the COVID-19 pandemic, AI models were developed to help with health-care resource issues, but previous studies showed that the datasets used often have limitations leading to biased outcomes.
  • A systematic review analyzed 192 healthcare datasets from MEDLINE and Google Dataset Search, focusing on metadata completeness, accessibility, and ethical considerations.
  • Results indicated significant shortfalls, including that only 48% showed the country of origin, 43% reported age, and under 25% included demographic factors like sex or race, emphasizing the need for improved data quality and transparency to avoid bias in future AI health applications.
View Article and Find Full Text PDF

Artificial intelligence as a medical device is increasingly being applied to healthcare for diagnosis, risk stratification and resource allocation. However, a growing body of evidence has highlighted the risk of algorithmic bias, which may perpetuate existing health inequity. This problem arises in part because of systemic inequalities in dataset curation, unequal opportunity to participate in research and inequalities of access.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to use clustering methods on transthoracic echocardiography (TTE) and hemodynamic parameters to identify subtypes of circulatory failure in patients with acute respiratory distress syndrome (ARDS) and to see how these relate to mortality compared to traditional definitions of right ventricular dysfunction (RVD).
  • Conducted at a university hospital ICU in Birmingham, UK, the retrospective study analyzed TTE data from 801 ICU patients diagnosed with ARDS over five years, revealing four distinct cardiovascular subphenotypes with varying 90-day mortality rates.
  • The findings suggest that these subphenotypes provide a better understanding of the underlying mechanisms of circulatory failure in ARDS and indicate that class 3 (dilated RV with impaired syst
View Article and Find Full Text PDF

Objectives: To describe current UK clinical practice around the use of intrathecal diamorphine as analgesia for major elective laparoscopic colorectal surgery.

Design: Online self-administered survey.

Setting: Acute public hospitals in the UK (National Health Service - NHS) .

View Article and Find Full Text PDF

Introduction: Survival from out of hospital cardiac arrest (OHCA) is lower in the UK than in several developed nations. Bystander cardiopulmonary resuscitation (CPR) is associated with increased rates of survival to hospital discharge following OHCA, prompting the introduction of several initiatives by the UK government to increase rates of bystander CPR, including the inclusion of Basic Life Support (BLS) teaching within the English national curriculum. While there is clear benefit in this, increasing evidence suggests poor retention of skills following BLS teaching.

View Article and Find Full Text PDF

Objectives: To assess whether right ventricular dilation or systolic impairment is associated with mortality and/or disease severity in invasively ventilated patients with coronavirus disease 2019 acute respiratory distress syndrome.

Design: Retrospective cohort study.

Setting: Single-center U.

View Article and Find Full Text PDF
Article Synopsis
  • Acute respiratory distress syndrome (ARDS) is a major cause of death in patients with SARS-CoV-2 pneumonia, often linked to a 'cytokine storm.'
  • The study compared ICU patients with ARDS caused by SARS-CoV-2 to those with ARDS from other infections, revealing differences in patient characteristics and treatment needs.
  • SARS-CoV-2 patients had fewer white blood cells and lower vasopressor use but needed longer mechanical ventilation, indicating they may require different management strategies.
View Article and Find Full Text PDF